Abstract
53BP1 is a p53 binding protein of unknown function that binds to the central DNA-binding domain of p53. It relocates to the sites of DNA strand breaks in response to DNA damage and is a putative substrate of the ataxia telangiectasia-mutated (ATM) kinase. To study the biological role of 53BP1, we disrupted the 53BP1 gene in the mouse. We show that, similar to ATM−/− mice, 53BP1-deficient mice were growth retarded, immune deficient, radiation sensitive, and cancer prone. 53BP1−/− cells show a slight S-phase checkpoint defect and prolonged G2/M arrest after treatment with ionizing radiation. Moreover, 53BP1−/− cells feature a defective DNA damage response with impaired Chk2 activation. These data indicate that 53BP1 acts downstream of ATM and upstream of Chk2 in the DNA damage response pathway and is involved in tumor suppression.
ACKNOWLEDGMENTS
We thank Andre Nussenzweig, Lewis Chodosh, Xiaohua Wu, Shirdar Ganesan, and David Livingston for valuable reagents and Larry Karnitz, Scott Kaufmann, and members of the Chen and Karnitz laboratories for helpful discussions. We are grateful to the Mayo Protein Core facility for synthesis of peptides and the Mayo Monoclonal Core facility for help in antibody production.
This work was supported by grants from National Institute of Health, the Breast Cancer Research Foundation, and Prospect Creek Foundation. J.C. is a recipient of DOD breast cancer career development award. I.W. is supported by a postdoctoral fellowship from the DOD Breast Cancer Research program.